Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BioNexus Gene Lab Corp

NASDAQ: BGLC · Industrial Applications and Services · 1 alert · CIK 1737523

Share price
$0.8200Close, Nov 16
Market cap
$2.41M
Shares outstanding
2.93MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BioNexus Gene Lab Corp filings on SEC EDGAR ↗

9:01 AM ET 8-K
Licensing Deal

BioNexus Gene Lab Licensing Deal with Ruanyun Edai Technology Inc. Worth $3.5M

BioNexus Gene Lab Corp. entered into an exclusive 10-year licensing agreement with Ruanyun Edai Technology Inc. (RYET) for the CogniAI document-intelligence platform in the Malaysian healthcare sector. The company will issue 410,000 shares to satisfy the $3.5 million license consideration and an additional 150,000 shares in exchange for 500,000 RYET ordinary shares. BioNexus intends to use the platform to target Malaysia's RM1 billion public healthcare digitalization program.

Value
$3.5M
Counterparty
Ruanyun Edai Technology Inc.
Term
10 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.